TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Viemed Healthcare ( (VMD) ).
On September 23, 2025, Viemed Healthcare announced the completion of its share repurchase program, having repurchased 1,976,441 common shares for approximately $13.2 million. This move underscores Viemed’s confidence in its long-term prospects and commitment to enhancing shareholder value, supported by a strong balance sheet and increasing free cash flow.
The most recent analyst rating on (VMD) stock is a Buy with a $7.50 price target. To see the full list of analyst forecasts on Viemed Healthcare stock, see the VMD Stock Forecast page.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.
Viemed Healthcare’s strong financial performance and positive earnings call sentiment are the primary drivers of its stock score. The company’s strategic growth initiatives and improved guidance enhance its outlook, despite liquidity challenges and mixed technical indicators.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
Viemed Healthcare, Inc. is a leading provider of in-home, technology-enabled post-acute respiratory care in the United States. The company offers a range of services including non-invasive ventilators, sleep therapy, staffing, and other complementary products, focusing on efficient in-home treatment with clinical practitioners providing therapy, education, and counseling.
Average Trading Volume: 265,518
Technical Sentiment Signal: Sell
Current Market Cap: $268.8M
See more insights into VMD stock on TipRanks’ Stock Analysis page.